Explorando Mckesson Always Advancing Cell And Gene Therapy
Al explorar Mckesson Always Advancing Cell And Gene Therapy encontramos varios datos interesantes.
- Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA)
- Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series.
- Not far from the vials and microscopes our researchers use to unlock the mysteries of the world's toughest diseases, you'll find ...
- Cell and gene therapies
- With the latest research, our understanding of the mechanisms induced by mesenchymal stem
Información detallada sobre Mckesson Always Advancing Cell And Gene Therapy
"Our group of experts in We're The global pharmaceutical industry is Joe DePinto, MBA, head of
Chair: Trent Carrier, Ph.D., Chief Operating Officer, L7 Informatics Speakers: Julien Cottineau, Ph.D., Chief Scientific Officer, ...
Vuelve pronto para consultar nuevas actualizaciones sobre Mckesson Always Advancing Cell And Gene Therapy.
